IP Library › Granted Patent US 7,550,274
Granted Patent B2
US 7,550,274 · App. 10/520,126 · Granted Jun 23, 2009

Glucose dehydrogenase

Assignee: Ultizyme International Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,550,274
App. No.
10/520,126
Granted
Jun 23, 2009
Kind
B2
Abstract

Disclosed is a modified glucose dehydrogenase having pyrroloquinoline quinone as a coenzyme, wherein one or more amino acid residues in a region of 186-206 amino acid of water-soluble PQQGDH derived from Acinetobacter calcoaceticus or in an equivalent region from other species are replaced with other amino acid residues. Also disclosed is a gene coding for the modified glucose dehydrogenase of the invention, a vector comprising the gene of the invention and a transformant comprising the vector, as well as a glucose assay kit and a glucose sensor comprising the modified glucose dehydrogenase of the invention.

Claims (14)

1. An isolated mutant water-soluble glucose dehydrogenase having pyrroloquinoline quinone as a coenzyme, wherein said mutant is a mutant of a glucose dehydrogenase comprising the amino acid sequence of SEQ ID NO: 1, and wherein said mutant consists of an amino acid substitution selected from the group consisting of:

(1) glutamine at position 168 of SEQ ID NO:1 is substituted with glycine, glutamic acid, leucine, phenylalanine, serine or aspartic acid, optionally combined with (a) a substitution wherein aspartate at position 143 of SEQ ID NO: 1 is substituted with glutamic acid or (b) a substitution wherein asparagine at position 428 of SEQ ID NO:1 is substituted with threonine;

(2) leucine at position 169 of SEQ ID NO:1 substituted with alanine, glycine, methionine, tryptophan or lysine, optionally combined with (a) a substitution wherein aspartate at position 143 of SEQ ID NO:1 is substituted with glutamic acid or (b) a substitution wherein asparagine at position 428 of SEQ ID NO:1 is substituted with threonine ; and

(3) aspartate at position 143 of SEQ ID NO:1 is substituted with glutamic acid and asparagine at position 428 of SEQ ID NO: 1 is substituted with threonine.

2. A glucose assay kit comprising the modified glucose dehydrogenase as claimed in claim 1 .

3. A glucose sensor comprising the modified glucose dehydrogenase as claimed in claim 1 .

4. The mutant glucose dehydrogenase as claimed in claim 1 , wherein glutamine at position 168 of SEQ ID NO:1 is substituted with glycine, glutamic acid, leucine, phenylalanine, serine or aspartic acid.

5. The mutant glucose dehydrogenase as claimed in claim 1 , wherein leucine at position 169 of SEQ ID NO:1 is substituted wit alanine, glycine, methionine, tryptophan or lysine.

6. The mutant glucose dehydrogenase as claimed in claim 1 , wherein aspartate at position 143 of SEQ ID NO:1 is substituted with glutamic acid, and asparagine at position 428 of SEQ ID NO:1 is substituted with threonine.

7. The mutant glucose dehydrogenase as claimed in claim 1 , wherein glutamine at position 168 of SEQ ID NO:1 is substituted with glycine, glutamic acid, leucine, phenylalanine, serine or aspartic acid in SEQ ID NO:1, and aspartate at position 143 of SEQ ID NO:1 is substituted wit glutamic acid.

8. The mutant glucose dehydrogenase as claimed in claim 1 , wherein glutamine at position 168 of SEQ ID NO:1 is substituted with glycine, glutamic acid, leucine, phenylalanine, serine or aspartic acid in SEQ ID NO:1, and asparagine at 428 of SEQ ID NO:1 is substituted with threonine.

9. The mutant glucose dehydrogenase as claimed in claim 1 , wherein leucine at position 169 of SEQ ID NO:1 is substituted with alanine, glycine, methionine, tryptophan or lysine and aspartate at position 143 of SEQ ID NO:1 is substituted wit glutamic acid.

10. The mutant glucose dehydrogenase as claimed in claim 1 , wherein leucine at 169 of SEQ ID NO:1 is substituted with alanine, glycine, methionine, tryptophan or lysine and asparagine at position 428 of SEQ ID NO:1 is substituted with threonine.

11. An isolated mutant water-soluble glucose dehydrogenase having pyrroloquinoline quinone as a coenzyme, wherein said mutant is a mutant of a glucose dehydrogenase comprising the amino acid sequence of SEQ ID NO:1, and wherein said mutant consist of an amino acid substitution wherein glutamine at position 168 of SEQ ID NO:1 is substituted with glycine, glutamic acid, leucine, phenylalanine, serine or aspartic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2007
From: SODE, KOJI
To: ULTIZYME INTERNATIONAL LTD.
Reel/Frame 018990/0104 →
Priority Claims (2)
JP 2002-196177 · Jul 4, 2002 · national
JP 2003-071760 · Mar 17, 2003 · national
Continuity (2)
Related Publication 20060257959A1 · Nov 16, 2006
Related Publication 20070134750A2 · Jun 14, 2007